Latest filing published 26 Jan 2018 for Agile Therapeutics INC.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Renee Selman: trading record in brief
Renee Selman discloses dealings in Agile Therapeutics Inc to SEC (Form 4). Over a trading history stretching from 11 May 2017 to 25 January 2018, the count stands at 4 filings.
On the market, this insider has only ever bought: 2 purchases, €201k in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 1 share grant and 1 option exercise.
Most recently, on 26 January 2018, the filings show an option exercise in Agile Therapeutics Inc. The clock since the last published purchase (28 August 2017) now reads 3,360 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Renee Selman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 17,500 sharesCommon StockSEC:0001104659-18-004313:0
- 6,455 shares@ US$3.327.9% of flowCommon StockSEC:0001104659-18-004313:1
- 7,250 shares@ US$3.359.4% of flowCommon StockSEC:0001104659-17-054006:0Canonical exit: 23 Nov 2017 (T+90)
- 53,333 shares@ US$3.6882.7% of flowCommon StockSEC:0001104659-17-032106:0Canonical exit: 9 Aug 2017 (T+90)
4 of 4 declarations